Multiple sclerosis - Diagnosis and treatment - Mayo Clinic
Nov 1, 2024 · Since then, over 20 drugs have become available for treatment of MS. And the potency of these drugs has increased over time to the point where we can almost completely …
Multiple sclerosis - Symptoms and causes - Mayo Clinic
Nov 1, 2024 · There are over 20 medications currently approved for prevention of MS attacks and prevention of new MRI lesions. As learning to function with MS can be challenging, there are …
Emerging treatments for multiple sclerosis - Mayo Clinic
Jul 3, 2024 · I was recently diagnosed with multiple sclerosis. Are there any new treatments to help me fight this disease? There is no cure for multiple sclerosis (MS). However, progress …
Multiple sclerosis: Symptoms and treatment - Mayo Clinic Press
May 30, 2025 · For primary progressive MS, ocrelizumab (Ocrevus) is the only FDA-approved disease-modifying therapy (DMT). For relapsing-remitting MS, several DMTs are available.
Emerging treatments for multiple sclerosis - Mayo Clinic Press
Jul 24, 2024 · About 10% to 15% of people with multiple sclerosis are diagnosed with a progressive form, called primary-progressive MS (PPMS), at the onset of the disease. A DMT …
Mayo Clinic Q and A: Managing multiple sclerosis: Types and …
Nov 26, 2024 · This article discusses managing multiple sclerosis, an autoimmune disease in which a person's immune system attacks the body.
Teriflunomide (oral route) - Side effects & dosage - Mayo Clinic
Nov 1, 2025 · Teriflunomide is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary …
Multiple sclerosis care at Mayo Clinic
Nov 1, 2024 · At Mayo Clinic, researchers are always working to develop new treatments to improve outcomes for people with MS. For example, Mayo Clinic was one of the first clinics to …
Fingolimod (oral route) - Side effects & dosage - Mayo Clinic
Dec 1, 2025 · Fingolimod is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive …
Ocrelizumab (intravenous route) - Side effects & uses
Oct 1, 2025 · Ocrelizumab injection is used to treat the relapsing forms (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease) or …